These changes improved health, especially in obese patients (body mass reduction), patients with diabetes (improved carbohydrate metabolism) or cardiovascular disease (normalization of blood pressure), and women with metabolic syndrome (fasting glucose, insulin sensitivity, abdominal obesity, lipid profile, and blood pressure all improved). This evidence concerns the gene INS and cardiovascular disorder.